News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Bausch Christoph Lawrence
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/16/2023 |
4
| Bausch Christoph Lawrence (COO) has filed a Form 4 on SAB Biotherapeutics, Inc.|
Txns:
| Granted 275,000 options to buy
@ $0.54, valued at
$148.5k
|
|
| 09/15/2022 |
4
| Bausch Christoph Lawrence (COO) has filed a Form 4 on SAB Biotherapeutics, Inc.|
Txns:
| Granted 274,875 options to buy
@ $0.71, valued at
$195.2k
|
|
| 03/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/24/2021 |
4/A
| Bausch Christoph Lawrence (Chief Science Officer) has filed a Form 4 on SAB Biotherapeutics, Inc.|
Txns:
| Granted 104,689 options to buy
@ $0.5, valued at
$52.3k
Granted 81,425 options to buy
@ $0.5, valued at
$40.7k
Granted 108,086 options to buy
@ $0 |
|
| 10/26/2021 |
4
| Bausch Christoph Lawrence (Chief Science Officer) has filed a Form 4 on SAB Biotherapeutics, Inc.|
Txns:
| Granted 104,689 options to buy
@ $0.5, valued at
$52.3k
Granted 81,425 options to buy
@ $0.5, valued at
$40.7k
Granted 69,793 options to buy
@ $0.5, valued at
$34.9k
Granted 11,632 options to buy
@ $1.25, valued at
$14.5k
Granted 108,086 options to buy
@ $0 |
|
| 10/22/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|